Proietti R, Rivera-Caravaca JM, Lopez-Galvez R, Harrison SL, Marin F, Underhill P, Shantsila E, McDowell G, Vinciguerra M, Davies R, Giebel C, Lane DA, Lip GYH. Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis. J Clin Med. 2023 Apr 11;12(8):2814. doi: 10.3390/jcm12082814. PubMed PMID: 37109151; PubMed Central PMCID: PMC10142574.
AÑO: 2023; IF: 3.0